363 related articles for article (PubMed ID: 15613479)
1. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
Mori T; O'Keefe BR; Sowder RC; Bringans S; Gardella R; Berg S; Cochran P; Turpin JA; Buckheit RW; McMahon JB; Boyd MR
J Biol Chem; 2005 Mar; 280(10):9345-53. PubMed ID: 15613479
[TBL] [Abstract][Full Text] [Related]
2. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
[TBL] [Abstract][Full Text] [Related]
3. Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture.
Giomarelli B; Schumacher KM; Taylor TE; Sowder RC; Hartley JL; McMahon JB; Mori T
Protein Expr Purif; 2006 May; 47(1):194-202. PubMed ID: 16300962
[TBL] [Abstract][Full Text] [Related]
4. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
Emau P; Tian B; O'keefe BR; Mori T; McMahon JB; Palmer KE; Jiang Y; Bekele G; Tsai CC
J Med Primatol; 2007 Aug; 36(4-5):244-53. PubMed ID: 17669213
[TBL] [Abstract][Full Text] [Related]
5. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
[TBL] [Abstract][Full Text] [Related]
6. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
O'Keefe BR; Vojdani F; Buffa V; Shattock RJ; Montefiori DC; Bakke J; Mirsalis J; d'Andrea AL; Hume SD; Bratcher B; Saucedo CJ; McMahon JB; Pogue GP; Palmer KE
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6099-104. PubMed ID: 19332801
[TBL] [Abstract][Full Text] [Related]
7. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
Fischer K; Nguyen K; LiWang PJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
[TBL] [Abstract][Full Text] [Related]
8. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
[TBL] [Abstract][Full Text] [Related]
9. Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin.
Micewicz ED; Cole AL; Jung CL; Luong H; Phillips ML; Pratikhya P; Sharma S; Waring AJ; Cole AM; Ruchala P
PLoS One; 2010 Dec; 5(12):e14360. PubMed ID: 21179548
[TBL] [Abstract][Full Text] [Related]
10. The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.
Xue J; Hoorelbeke B; Kagiampakis I; Demeler B; Balzarini J; Liwang PJ
Antimicrob Agents Chemother; 2013 Aug; 57(8):3976-89. PubMed ID: 23752505
[TBL] [Abstract][Full Text] [Related]
11. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
[TBL] [Abstract][Full Text] [Related]
12. Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
Kagiampakis I; Gharibi A; Mankowski MK; Snyder BA; Ptak RG; Alatas K; LiWang PJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):264-75. PubMed ID: 20956603
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.
Férir G; Palmer KE; Schols D
Virology; 2011 Sep; 417(2):253-8. PubMed ID: 21802104
[TBL] [Abstract][Full Text] [Related]
14. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
[TBL] [Abstract][Full Text] [Related]
15. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.
Banerjee K; Michael E; Eggink D; van Montfort T; Lasnik AB; Palmer KE; Sanders RW; Moore JP; Klasse PJ
AIDS Res Hum Retroviruses; 2012 Feb; 28(2):206-14. PubMed ID: 21793733
[TBL] [Abstract][Full Text] [Related]
16. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains.
Férir G; Huskens D; Palmer KE; Boudreaux DM; Swanson MD; Markovitz DM; Balzarini J; Schols D
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1513-23. PubMed ID: 22607556
[TBL] [Abstract][Full Text] [Related]
17. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
[TBL] [Abstract][Full Text] [Related]
18. Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.
Moulaei T; Alexandre KB; Shenoy SR; Meyerson JR; Krumpe LR; Constantine B; Wilson J; Buckheit RW; McMahon JB; Subramaniam S; Wlodawer A; O'Keefe BR
Retrovirology; 2015 Jan; 12():6. PubMed ID: 25613831
[TBL] [Abstract][Full Text] [Related]
19. Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.
Férir G; Huskens D; Noppen S; Koharudin LM; Gronenborn AM; Schols D
J Antimicrob Chemother; 2014 Oct; 69(10):2746-58. PubMed ID: 24970741
[TBL] [Abstract][Full Text] [Related]
20. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.
Alexandre KB; Gray ES; Lambson BE; Moore PL; Choge IA; Mlisana K; Karim SS; McMahon J; O'Keefe B; Chikwamba R; Morris L
Virology; 2010 Jun; 402(1):187-96. PubMed ID: 20392471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
